Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial}, Source: Eur Respir J 2012; 40: 548-554 Year: 2012
Aural electrical stimulation for smoking cessation – a double-blind, placebo controlled study Source: Eur Respir J 2005; 26: Suppl. 49, 388s Year: 2005
Randomized clinical trials with nicotine inhaler for smoking cessation Source: Eur Respir J 2003; 22: Suppl. 45, 166s Year: 2003
A multicenter, randomised, double-blind, placebo-controlled 6 month trial to evaluate efficacy and tolerability of bupropion hydrochloride sustained release (SR) tablets as treatment for nicotine dependency in healthcare workers and as an aid to smoking Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002
Efficacy and safety of a novel nicotine mouth spray in smoking cessation: A randomized, placebo-controlled, double blind, multicenter study with 52-week follow up Source: Annual Congress 2011 - Smoking cessation science Year: 2011
A randomised, double-blind, placebo-controlled phase 3 study investigating the efficacy of nicotine substitution (NS) on nicotine withdrawal symptoms (NWS) in hospitalised smokers (HS) Source: Annual Congress 2009 - Smoking cessation Year: 2009
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017 Year: 2017
A placebo-controlled trial with varenicline for long term nicotine replacement product users Source: Annual Congress 2011 - Smoking cessation science Year: 2011
Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018
Electronic cigarettes for smoking cessation: an individual patient meta-analysis of randomized controlled trials Source: International Congress 2019 – Old and new approaches to support tobacco cessation Year: 2019
The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002
The safety and immunogenicity of a conjugated nicotine vaccine: results from a double-blind, placebo-controlled trial in healthy smokers and non-smokers Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004
Impact of oral clonidine on duration of opioid and benzodiazepine use in mechanically ventilated children: a randomized, double-blind, placebo-controlled study Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes Year: 2020
Short-term low-dose vs standard-dose Varenicline therapy for smoking cessation: a randomized controlled trial. Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes Year: 2017
A controlled trial of nortriptyline or sustained-release bupropion for smoking cessation Source: Annual Congress 2004 - Issues in tobacco control Year: 2004
Late Breaking Abstract: Randomized, placebo-controlled trial of varenicline for smoking cessation with flexible quit dates Source: Annual Congress 2010 - Smoking related disorders and smoking cessation Year: 2010
Cigarette smoke retention and bronchodilation in patients with COPD: A controlled randomized trial Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
A randomized double-blind placebo-controlled trial on the short and long-term effects of electro acupuncture on moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006
Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial Source: Annual Congress 2010 - COPD exacerbation Year: 2010